MusclePharm Corp (OTCMKTS:MSLP) lost over 50% of its value yesterday after weaker than expected Fourth-Quarter results as well as a disastrous Earnings Call at the end of which CEO Brad Pyatt skipped the Q&A altogether.
Mr. Pyatt stated ”Over the past five years, we have grown substantially, reaching $177 million in net revenue, up from $110 million last year. Putting that in perspective, in 2010 we were at $3.2 million in sales for the year. That is truly impressive growth and something we would encourage you to focus on, as well as the fact that, on a non-GAAP basis removing non-cash expenses, we are profitable.”
MusclePharm Corp (OTCMKTS:MSLP) is a rapidly expanding healthy life-style company that develops and manufactures a full line of NSF and scientifically approved nutritional supplements that are 100% free of any banned substances. Based on years of research, MusclePharm products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists, and field tested by more than 100 elite professional athletes from various sports including the NFL, MMA, and MLB.
The Company’s propriety and award winning products address all categories of an active lifestyle including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in over 120 countries and available in over 5,000 U.S. retail outlets that include GNC and Vitamin Shoppe, as well as over 100 online stores, including bodybuilding.com, Amazon and Vitacost.com.
MusclePharm offers a complete range of powders, capsules, tablets and gels. Its portfolio of recognized brands, including MusclePharm(R) Hybrid and Core Series, Arnold Schwarzenegger Series(TM) and FitMiss(TM), are marketed and sold in more than 110 countries and available in over 35,000 retail outlets globally.
In 2014 MSLP launched the Arnold Schwarzenegger Series. All five products in the series are now available online in addition to being sold in over 4,000 GNC stores. MusclePharm has also reached an agreement with Walmart (NYSE:WMT) to have two of the products in Arnold line carried in 3,500 stores and one product carried in 642 Sam’s Club locations.
The Company got some big celebrity endorsements in 2014 including Arnold Schwarzenegger, Tiger Woods, Johnny Manziel and Jen Selter. They also closed the BioZone Pharmaceuticals acquisition in an all-stock deal.
To Find out the inside Scoop on MSLP Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
MSLP developed more than 180 new items (and many would suggest here is where the problem lies), including new products, new flavors and new sizes in the U.S. and international markets in 2014. This includes launch of mass consumer products such as CocoProtein(TM) and Combat Crunch(TM) as part of Company’s initiative to address the entire spectrum of the sports nutrition industry.
The Combat Crunch protein bar is a three layer bar that is comparable in softness to a soft-batch cookie; the product seems to be wildly popular quickly rising to BodyBuilding.com’s Top-50 Bestseller List.
On March 15 MSLP announced they launched an exclusive brand for Bodybuilding.com: The MusclePharm Hardcore Series — a series of products designed for the high-performing athlete with no propriety blends.
The Hardcore Series is the latest innovation by MusclePharm aimed at providing elite bodybuilding enthusiasts a new product line to maximize muscle gain and enhance everyday performance.
MSLP CEO Brad Pyatt stated “At MusclePharm, we take pride in tailoring our products to our customers’ needs, and the Hardcore Series was designed with serious and educated athletes in mind. Like all of our products, this series includes only the best ingredients and no proprietary blends. Backed by science and built by sweat, the Hardcore Series is a line of cutting-edge supplements that are among the most powerful supplements on the market.”
We have a Monster Pick Coming. Subscribe Right Now!
Currently trading at a $50 million market valuation MSLP is coming back some after dropping to as low as $2.78. The stock has lost over $60 million in market valuation in recent days. Clearly shareholders are very, very unhappy with the direction that management is taking here – what a difference a day makes; this was a $14 stock a few months ago. We will be updating on MSLP when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with MSLP.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: we hold no position in MSLP either long or short and we have not been compensated for this article.